首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Journal of diabetes science and technology

缩写:

ISSN:1932-2968

e-ISSN:1932-2968

IF/分区:3.7/Q2

文章目录 更多期刊信息

共收录本刊相关文章索引3804
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
David Rankin,Barbara Kimbell,Janet M Allen et al. David Rankin et al.
Background: Closed-loop technology may help address health disparities experienced by adolescents, who are more likely to have suboptimal glycemic control than other age groups and, because of their age, find diabetes sel...
Marie Auzanneau,Joachim Rosenbauer,Werner Maier et al. Marie Auzanneau et al.
Background: Despite increasing use of technology in type 1 diabetes, persistent ethnic and socio-economic disparities have been reported. We analyzed how the use of insulin pump therapy and continuous glucose monitoring (...
David Tsai,Jaquelin Flores Garcia,Jennifer L Fogel et al. David Tsai et al.
Background: Diabetes technologies, such as insulin pumps and continuous glucose monitors (CGM), have been associated with improved glycemic control and increased quality of life for young people with type 1 diabetes (T1D)...
Manuel M Eichenlaub,Natasha A Khovanova,Mary C Gannon et al. Manuel M Eichenlaub et al.
Background: Current mathematical models of postprandial glucose metabolism in people with normal and impaired glucose tolerance rely on insulin measurements and are therefore not applicable in clinical practice. This rese...
Giacomo Cappon,Luca Cossu,Federico Boscari et al. Giacomo Cappon et al.
We present a new mobile platform to be used in clinical trials aimed at both collecting data and assessing new technologies and treatments for diabetes care. The main components of the platform are a mobile app, that automatically collects ...
Dana Lewis Dana Lewis
Originally, the future of automated insulin delivery (AID) systems, or artificial pancreas systems (APS), was having them at all, in any form. We've learned in the last half dozen years that the future of all artificial pancreas systems hol...